MarketPulse

CDK4/6 inhibitor

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Relay Therapeutics

Relay Therapeutics Advances Breast Cancer Drug Combo Toward Phase 3 Trial

Relay Therapeutics reports positive Phase 2 data for zovegalisib triplet combination in metastatic breast cancer, planning Phase 3 launch in early 2027.
PFERLAYPhase 3 trialzovegalisib
BenzingaBenzinga··Vandana Singh

Roche's Breast Cancer Drug Falls Short in Pivotal Trial, Stock Drops 5%

Roche's giredestrant failed to meet primary endpoint in Phase 3 breast cancer trial, causing 5% stock decline. Company plans adjuvant trial readout in 2027.
LLYNVORHHBYclinical trial failurePhase 3 trial